Most (61%) ‘first time’ users did not fill another prescription in the next two years while 22% did so sporadically.
The research will be presented at the Thoracic Society of Australia and New Zealand (TSANZ) Conference which starts this Sunday in Melbourne.
The study was conducted by the Australian Centre for Asthma Monitoring, a collaborating unit of the Australian Institute of Health and Welfare based at the Woolcock Institute of Medical Research in Sydney. It analysed the anonymous Pharmaceutical Benefits Scheme (PBS) records of individuals who filled a prescription for preventer medications for asthma for the first time between July 2004 and June 2005, and their subsequent prescription activity over a period of two years. The most commonly used form of preventer medication is inhaled corticosteroids.
Professor Guy Marks, Head of Epidemiology Research at the Woolcock Institute, said the results indicated that the prevalence of one-time and sporadic use was highest in young adults (age 15-34 years) with regular use most common in adults aged 65 years and over.
“The PBS dataset is a valuable tool for assessing patterns of asthma medication use,” he said.
“Importantly this study shows that while guidelines recommend regular use of preventer medication, this certainly isn’t happening in the community. At least some of those people who are now using preventer medication sporadically, could be expected to benefit from regular use of this class of medications.
The results of the study will be presented at the upcoming Thoracic Society of Australia and New Zealand (TSANZ) Conference being held in Melbourne from March 30 to April 2.
Professor Marks will present the abstract titled Patterns Of Asthma Medication Use: An Australian Population-Based Longitudinal Cohort Study on the afternoon of Monday 31 March.
The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung
A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences